Treatments for the Brain

How more effective treatments are being developed through an understanding of the neural basis of cognitive, emotional and behavioural dysfunction

Prof. Barbara Sahakian, University of Cambridge

  • Mon 5th Feb 2018
  • 19:30
  • The Wolfson Hall, Churchill College, Storey's Way, Cambridge, CB3 0DS
  • Add to calendar

View location

Lecture details to follow

Prof. Sahakian's research is aimed at understanding the neural basis of cognitive, emotional and behavioural dysfunction in order to develop more effective pharmacological and psychological treatments. The focus of her lab is on early detection, differential diagnosis and proof of concept studies using cognitive enhancing drugs. This research utilises neuropsychological tests, such as the CANTAB tests, which she co-invented and a focus remains on the development of novel tests. Current study participants include healthy volunteers and patient groups with brain injury, Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), obsessive compulsive disorder, substance abuse, depression and mania. Techniques used include psychopharmacological, neuropsychological, neuroimaging (fMRI and PET) and genetic ones. Results from recent studies of ecstasy use and cognitive enhancement using methylphenidate, modafinil and atomoxetine have led to an interest in pharmacogenomics and neuroethics.

The lecture will be preceded by a short presentation from a CSAR PhD Student Award winner

Ed Kay - Intelligent stethoscope for low income countries